Clinical Trials Directory

Trials / Completed

CompletedNCT02427828

VRES Study in Two Phases to Monitor Cardiac Surgical Patients Following Discharge From ICU

Continuous, Ambulatory, Non Invasive, Vital Sign Monitoring Using VRES of Cardiac Surgical Patients Following Discharge From Intensive Care. Impact on Detection of Physiological Deterioration

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
208 (actual)
Sponsor
OBS Medical Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Failure to recognise deterioration early is a major cause of preventable deaths amongst hospital patients. The investigators wish to study whether continuous monitoring of 'vital signs' (pulse rate, breathing rate, and blood oxygen saturations) with computer modeled alerting to detect patient deteriorations can reduce cardiac arrest rate and critical care readmissions from the wards by alerting staff to clinical deteriorations more effectively than current paperbased systems. Continuous monitoring of 'vital signs' can be achieved in two ways. Continuous monitoring of 'vital signs' has traditionally been restricted to the bedside because of the need for the patient to be connected by wires to the monitor. More recently, advances in telemetry (wireless technology) have allowed the development of wearable devices which allow patients to mobilise freely, whilst constantly monitoring these 'vital signs'.

Conditions

Interventions

TypeNameDescription
DEVICEVisensia Respiration Rate Estimation Service (VRES)Medical device product to provide respiration rate from PPG signal

Timeline

Start date
2013-03-01
Primary completion
2014-06-01
Completion
2014-07-01
First posted
2015-04-28
Last updated
2015-04-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02427828. Inclusion in this directory is not an endorsement.